Dr. Georgia Mitsi, Founder and CEO of Apptomics, a digital health company that is developing tools to help patients better manage chronic neurological diseases, such as Parkinson’s Epilepsy, Huntington’s, and Alzheimer’s joins eHealth Radio and the Health Care & Technology Channels.
Listen to interview with host Eric Michaels & guest Dr. Georgia Mitsi discuss the following:
- Sometimes companies are started due to a personal crisis or fundamental underlying capability. What promoted the formation of Apptomics?
- What kinds of patients can benefit from Apptomics technology?
- How do the tools that Apptomics is developing help patients with chronic diseases better manage their care?
- Are these tools just for patients?
- What is your vision for the company and how it can help patients?
Apptomics LLC, is a digital health firm developing mobile applications and wearable sensors for neurological conditions. These conditions are characterized by complexity, poorly served by difficult access to care, long spans between visits, and ultimately limited data on which to base treatment decisions. Apptomics’s products offer a support system for patients and caregivers in between consultations allowing for active management of their condition and supporting the clinical decision-making with data. Our products allow personalized drug adjustments as needed and focus on other aspects such as exercise, diet, depression etc. They could lead to improved health outcomes and decreased costs. Our apps will be clinically validated and FDA approved where applicable. Collaborations with distinguished academic institutions will add credibility and strategic partnerships will support future growth and drive customer adoption.
Apptomics was founded in 2012 as a company specializing in transforming the current patient-physician interaction with the power of scientifically-designed and validated mobile applications. We are passionate about developing easy tools to empower patients and transform the traditional way of caring for chronic neurological conditions.
The company is led by Dr. Georgia Mitsi who has degrees in pharmacoepidemiology (PhD) and business (MBA). She is responsible for the vision and the strategy of Apptomics by leading the executive team to further disrupt traditional healthcare approaches. Dedicated wholeheartedly to patients, Apptomics is committed to improving their quality of life and health outcomes through scientifically valid mobile applications. The company has a strong scientific advisory board of leaders in neurological disorders.